Triazolam 0.125 mg, 0.25 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 0.125 mg, 0.25 mg

Reference Brands: Halcion (USA)

Category: Neurology

Triazolam is a Neurology product available as Tablets in strengths 0.125 mg, 0.25 mg. It corresponds to the reference brand Halcion (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Product Description:

Triazolam is a short-acting central nervous system (CNS) depressant belonging to the triazolobenzodiazepine class, a subgroup of benzodiazepine derivatives. It is widely recognized for its potent sedative and hypnotic effects and is primarily used in the short-term treatment of severe and acute insomnia. Triazolam is marketed under the brand name Halcion and other approved generic formulations in regulated markets.

Pharmacologically, triazolam enhances the inhibitory action of gamma-aminobutyric acid (GABA) in the brain, resulting in pronounced sedative, anxiolytic, amnesic, anticonvulsant, and muscle-relaxant properties. Due to its rapid onset of action and short elimination half-life, triazolam is particularly effective in inducing sleep while minimizing residual morning drowsiness. Its effects typically promote sleep for a limited duration, making it suitable for sleep-onset difficulties rather than sleep maintenance.

In addition to insomnia management, triazolam is sometimes used as an adjunct in medical and dental procedures requiring sedation, as well as to reduce anxiety during short diagnostic procedures such as MRI scans. Triazolam was first patented in 1970 and approved for use in the United States in 1982, and it remains a commonly prescribed hypnotic when used under strict medical supervision.

Controlled medicine — licensed supply only

This product is controlled in many countries under narcotic, psychotropic, precursor or other drug laws, which vary by country. We supply only licensed buyers holding any import certificate, permit or authorisation their national authority requires, and the Indian manufacturer or exporter must hold the required licences. In India, each export of a narcotic drug or psychotropic substance needs an export authorisation, and export of ephedrine, pseudoephedrine or their preparations a No Objection Certificate, from the Narcotics Commissioner (Central Bureau of Narcotics). We verify permits before quoting.